Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral

SIMPLE SUMMARY: Secreted glycoprotein thrombospondin-2 (TSP-2) is a predictive biomarker of hepatocellular carcinoma (HCC) occurrence in chronic hepatitis C (CHC) patients after HCV elimination by direct-acting antiviral agents (DAAs). The AFT score using TSP-2, AFP, and the FIB-4 index may identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumae, Takayuki, Kodama, Takahiro, Tahata, Yuki, Myojin, Yuta, Doi, Akira, Nishio, Akira, Yamada, Ryoko, Nozaki, Yasutoshi, Oshita, Masahide, Hiramatsu, Naoki, Morishita, Naoki, Ohkawa, Kazuyoshi, Hijioka, Taizo, Sakakibara, Mitsuru, Doi, Yoshinori, Kakita, Naruyasu, Yakushijin, Takayuki, Sakamori, Ryotaro, Hikita, Hayato, Tatsumi, Tomohide, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856394/
https://www.ncbi.nlm.nih.gov/pubmed/36672412
http://dx.doi.org/10.3390/cancers15020463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856394/
https://www.ncbi.nlm.nih.gov/pubmed/36672412
http://dx.doi.org/10.3390/cancers15020463

Ejemplares similares